Oxford Capital Partners

Oxford Capital Partners appeared to be the VC, which was created in 1999. The company was established in Europe in United Kingdom. The leading representative office of defined VC is situated in the Oxford.

The typical startup value when the investment from Oxford Capital Partners is 10-50 millions dollars. The high activity for fund was in 2008. Despite it in 2019 the fund had an activity. The fund is generally included in 7-12 deals every year. Considering the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2011. Opposing the other organizations, this Oxford Capital Partners works on 20 percentage points less the average amount of lead investments. The common things for fund are deals in the range of 1 - 5 millions dollars.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Oxford Capital Partners, startups are often financed by Oxford Technology Management, South East Growth Fund & Management, Herald Ventures. The meaningful sponsors for the fund in investment in the same round are Seraphim Capital, South East Growth Fund & Management, MTI. In the next rounds fund is usually obtained by Seraphim Capital, MTI, Carbon Trust.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Sphere Medical Holding, Celoxica, Veryan Medical We can highlight the next thriving fund investment areas, such as Health Care, Health Diagnostics.

The fund was created by David Mott, Edward Mott. We also calculated 18 valuable employees in our database.

Notable deals

Review

• No reviews are submitted yet.